Drug screening at single-organoid resolution via bioprinting and interferometry PJ Tebon, B Wang, AL Markowitz, A Davarifar, BL Tsai, P Krawczuk, ... Nature communications 14 (1), 3168, 2023 | 43 | 2023 |
Screening for Protein-Protein Interaction Inhibitors Using a Bioluminescence Resonance Energy Transfer (BRET)–Based Assay in Yeast C Corbel, S Sartini, E Levati, P Colas, L Maillet, C Couturier, B Montanini, ... SLAS DISCOVERY: Advancing Life Sciences R&D 22 (6), 751-759, 2017 | 18 | 2017 |
New Antimicrobials Targeting Bacterial RNA Polymerase Holoenzyme Assembly Identified with an in Vivo BRET-Based Discovery Platform S Sartini, E Levati, M Maccesi, M Guerra, G Spadoni, S Bach, ... ACS Chemical Biology 14 (8), 1727-1736, 2019 | 10 | 2019 |
Moonlighting transcriptional activation function of a fungal sulfur metabolism enzyme E Levati, S Sartini, A Bolchi, S Ottonello, B Montanini Scientific Reports 6 (1), 25165, 2016 | 10 | 2016 |
Dry and wet approaches for genome-wide functional annotation of conventional and unconventional transcriptional activators E Levati, S Sartini, S Ottonello, B Montanini Computational and structural biotechnology journal 14, 262-270, 2016 | 6 | 2016 |
The landscape of drug sensitivity and resistance in sarcoma A Al Shihabi, PJ Tebon, HTL Nguyen, J Chantharasamee, S Sartini, ... bioRxiv, 2023.05. 25.542375, 2023 | 5 | 2023 |
An Optimized Workflow for the Discovery of New Antimicrobial Compounds Targeting Bacterial RNA Polymerase Complex Formation A Caputo, S Sartini, E Levati, I Minato, GM Elisi, A Di Stasi, C Guillou, ... Antibiotics 11 (10), 1449, 2022 | 4 | 2022 |
Cervical organoids go viral S Sartini, A Soragni Cell stem cell 28 (8), 1337-1338, 2021 | 1 | 2021 |
Mutant p53 Misfolding and Aggregation Precedes Transformation into High-Grade Serous Ovarian Carcinoma S Sartini, L Omholt, N Moatamed, A Soragni. bioRxiv, 2024.09.17.612958, 2024 | | 2024 |
p53 aggregation promotes transformation from non-malignant lesions to high-grade serous ovarian carcinomas S Sartini, L Omholt, NA Moatamed, A Soragni Cancer Research 84 (6_Supplement), 3027-3027, 2024 | | 2024 |
Protein aggregation in sarcoma as a target for therapy S Sartini, H Le, A Soragni Cancer Research 83 (7_Supplement), 2582-2582, 2023 | | 2023 |
A characterization of drug sensitivity and resistance in sarcoma AA Shihabi, PJ Tebon, HT Nguyen, J Chantharasamee, S Sartini, ... Cancer Research 83 (7_Supplement), 203-203, 2023 | | 2023 |
A pipeline for functional precision medicine in bone and soft tissue sarcoma organoids A Al Shihabi, PJ Tebon, J Chantharasamee, HT Nguyen, S Sartini, ... Cancer Research 82 (12_Supplement), 3078-3078, 2022 | | 2022 |
Antibiotic compounds targeting bacterial RNA polymerase holoenzyme assembly and other protein-protein interaction inhibitiors identified with an in vivo-bret drug discovery … S SARTINI Università di Parma. Dipartimento di Scienze chimiche, della vita e della …, 2018 | | 2018 |
Yeast-BRET: a high-throughput screening platform for the characterization of protein-protein interaction inhibitors S Sartini, C Corbel, E Levati, G Dieci, L Maillet, P Colas, C Couturier, ... YEAST 32, 187-187, 2015 | | 2015 |